...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: BETting on a new heart failure treatment

This ties in very nicely with the mouse model work that was done a few years back at Harvard or Oxford (I can't remember off hand) that suggested Apabetalone (RVX-208) could potentially be a treatment for heart failure. I really wish RVX IR was more on top of this type of information and start connecting third party validation dots like this for potential investors. 

Share
New Message
Please login to post a reply